309 related articles for article (PubMed ID: 23028204)
1. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.
Simó-Servat O; Hernández C; Simó R
Mediators Inflamm; 2012; 2012():872978. PubMed ID: 23028204
[TBL] [Abstract][Full Text] [Related]
2. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.
Suzuki Y; Nakazawa M; Suzuki K; Yamazaki H; Miyagawa Y
Jpn J Ophthalmol; 2011 May; 55(3):256-263. PubMed ID: 21538000
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
4. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499
[TBL] [Abstract][Full Text] [Related]
6. Decreased angiogenin concentration in vitreous and serum in proliferative diabetic retinopathy.
Marek N; Raczyńska K; Siebert J; Myśliwiec M; Zorena K; Myśliwska J; Reiwer-Gostomska M; Trzonkowski P
Microvasc Res; 2011 Jul; 82(1):1-5. PubMed ID: 21539846
[TBL] [Abstract][Full Text] [Related]
7. Vitreous expression of cytokines and growth factors in patients with diabetic retinopathy-An investigation of their expression based on clinical diabetic retinopathy grade.
Deuchler S; Schubert R; Singh P; Chedid A; Brui N; Kenikstul N; Kohnen T; Ackermann H; Koch F
PLoS One; 2021; 16(5):e0248439. PubMed ID: 34010297
[TBL] [Abstract][Full Text] [Related]
8. Novel vitreous modulators for pharmacologic vitreolysis in the treatment of diabetic retinopathy.
Costa Ede P; Rodrigues EB; Farah ME; Sebag J; Meyer CH
Curr Pharm Biotechnol; 2011 Mar; 12(3):410-22. PubMed ID: 20939794
[TBL] [Abstract][Full Text] [Related]
9. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Funatsu H; Yamashita H; Nakanishi Y; Hori S
Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
[TBL] [Abstract][Full Text] [Related]
11. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.
Nawaz IM; Rezzola S; Cancarini A; Russo A; Costagliola C; Semeraro F; Presta M
Prog Retin Eye Res; 2019 Sep; 72():100756. PubMed ID: 30951889
[TBL] [Abstract][Full Text] [Related]
12. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
[TBL] [Abstract][Full Text] [Related]
13. Vitreous proteomics and diabetic retinopathy.
Walia S; Clermont AC; Gao BB; Aiello LP; Feener EP
Semin Ophthalmol; 2010; 25(5-6):289-94. PubMed ID: 21091014
[TBL] [Abstract][Full Text] [Related]
14. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
15. Vitreous biomarkers in diabetic retinopathy: a systematic review and meta-analysis.
McAuley AK; Sanfilippo PG; Hewitt AW; Liang H; Lamoureux E; Wang JJ; Connell PP
J Diabetes Complications; 2014; 28(3):419-25. PubMed ID: 24630762
[TBL] [Abstract][Full Text] [Related]
16. Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy.
Yokoi M; Yamagishi SI; Takeuchi M; Ohgami K; Okamoto T; Saito W; Muramatsu M; Imaizumi T; Ohno S
Br J Ophthalmol; 2005 Jun; 89(6):673-5. PubMed ID: 15923499
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Proteomics Analysis of Vitreous Humor from Diabetic Retinopathy Patients.
Loukovaara S; Nurkkala H; Tamene F; Gucciardo E; Liu X; Repo P; Lehti K; Varjosalo M
J Proteome Res; 2015 Dec; 14(12):5131-43. PubMed ID: 26490944
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of vitreous humor chemokines in type 2 diabetic patients with and without diabetic retinopathy.
Zeng Y; Cao D; Yu H; Hu Y; He M; Yang D; Zhuang X; Zhang L
Acta Diabetol; 2019 Jul; 56(7):797-805. PubMed ID: 30911832
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
Chen W; Lu Q; Lu L; Guan H
Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometry-Based Vitreous Proteomics: Validated Methods and Analysis Pipeline.
Weber S; Carruthers N; Gates C; Zhao Y; Sundstrom J
Methods Mol Biol; 2023; 2678():157-167. PubMed ID: 37326711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
